Project Grant P30CA275774
Award Date 4/1/26
Completion Date 3/31/29
Dollars Obligated $1.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Urbana, IL 61801, USA
Similar Awards
- Federal Grant Award Summary The National Cancer Institute awarded the University of Illinois a $386,279 Project Grant on July 10, 2025, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop innovative immunotherapy screening capabilities. The grant funds the creation of a microfluidic device cassette and associated functional immune assay protocols designed to enable personalized immunotherapy screening directly on core needle biopsies from cancer patients. This...
- Federal Grant Award Summary The University of Chicago received a $372,628 Project Grant from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) effective September 12, 2025, through August 31, 2028. This award supports the development and advancement of spatiomolecular profiling technologies for cancer research, specifically building upon the institution's Array-Seq large-format spatially resolved transcriptomics (ST) platform. The project...
- Federal Grant Award Summary The University of Illinois received a $573,470 Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394), with an award date of August 25, 2025, and completion date of July 31, 2030. The grant supports the development of Resonance Enhanced Null-Deflection Infrared (RENDIR) Spectroscopic Imaging, an advanced atomic force microscopy-infrared (AFM-IR) technology platform designed to enable...
- Federal Grant Award Summary The University of Illinois received a $544,520 Project Grant award from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395) on April 7, 2026, for the development of a microRNA (miRNA)-based therapeutic approach targeting pediatric high-grade gliomas (PHGGs). The project, scheduled for completion by March 31, 2031, aims to develop a tumor-targeting therapeutic agent specifically designed for PHGGs on a molecular basis. The research...
- Federal Project Grant Award Summary The University of Chicago received a $464,212 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) awarded on August 1, 2025, with a completion date of July 31, 2030. This five-year project supports research characterizing cancer susceptibility mechanisms associated with the TERT/CLPTM1L locus at chromosome 5p15.33, a highly pleiotropic genetic region linked to increased risk for over 15...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded $185,760 to the University of Chicago under the Cancer Research Manpower program (CFDA 93.398) on September 15, 2025, for a research project titled "Targeting Glycerol Metabolism in Anti-Tumor Immunity." The award supports a three-year project (concluding August 31, 2028) investigating the mechanistic relationship between glycerol metabolism and CD8+ T cell function in the context of obesity-related...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant of $584,510 to the University of Colorado-Denver on September 12, 2025, under the Cancer Biology Research program (CFDA 93.396) to support the development and implementation of advanced spatial transcriptomics and proteomics technologies for studying tumor microenvironments. Through the Human Immune Monitoring Shared Resource (HIMSR) at the University of Colorado Cancer Center, this funding supports a...
- Federal Grant Award Summary The University of Iowa received a $2,185,934 Project Grant from the National Cancer Institute (NCI) under the Cancer Centers Support Grants program (CFDA 93.397), awarded August 28, 2025, with completion targeted for July 31, 2030. This Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer award supports innovative translational research addressing neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs)—rare, orphan cancers...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $2.1 million Project Grant from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) awarded on September 23, 2025, with a completion date of August 31, 2029. The award supports translational research to determine genotypic, phenotypic, and evolutionary trajectories of treatment resistance to radiotherapy, addressing a critical gap in personalized cancer...
- Federal Grant Award Summary The University of Chicago received a $361,807 Project Grant award from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395) on June 1, 2025, with a completion date of May 31, 2028. This planning grant (R34) supports the tailoring and refinement of an engaging technology-assisted cognitive behavioral therapy (TCBT) intervention called MYTH for adolescents and young adults (AYA) diagnosed with hematological malignancies. The award...